Today: 12 June 2026
Browse Category

NASDAQ:INTC 6 June 2026 - 12 June 2026

Charles Schwab Expands Money Talk as Fresh Filings Show Farallon, Elevation Point Cut SCHW Stakes

Options Get Attention as Schwab’s STAX Bounces With AI Stocks

Schwab’s Trading Activity Index jumped to 55.08 in May from 50.10 in April as retail investors returned to equities—especially tech stocks—while also shifting toward ETFs and options for risk management, signaling renewed participation in the AI-led rally but with increased caution, according to Schwab’s monthly data.
12 June 2026
············
Intel Shares Face Early Test After Google-Driven Spike

Intel Shares Surge 9% After BofA Double Upgrade on AI Chip Momentum

Intel soared 9.27% to $116.96 after Bank of America upgraded the stock to Buy from Underperform and hiked its price target to $135, citing higher confidence in Intel’s AI and foundry prospects and a sharply increased server CPU market estimate; the rally followed reports Google ordered over 3 million chips from Intel and came amid a 7.9% surge in the PHLX Semiconductor Index.
12 June 2026
··
Nvidia, Broadcom, Applied Materials, Intel, Oracle lead AI infrastructure stocks

Nvidia, Broadcom, Applied Materials, Intel, Oracle lead AI infrastructure stocks

Nvidia tops the new AI infrastructure buy list as it expands beyond chips, joining a $10 billion Helix Digital Infrastructure launch; Broadcom surges with a $35 billion AI XPV Platform, Applied Materials wins analyst upgrades after Singapore expansion, Intel gets a BofA upgrade on AI CPU demand, while Oracle faces funding risks after a sharp post-earnings selloff despite record cloud growth. (Reuters)
11 June 2026
·······
Intel Drops as Chip Selloff Hits Shares Despite Google AI Bid Hopes

Intel Drops as Chip Selloff Hits Shares Despite Google AI Bid Hopes

Intel shares fell 0.8% to $107.04 as the stock’s main catalyst—a reported Google order for over 3 million Intel-made TPUs for 2028—remains unconfirmed, while the Philadelphia Semiconductor Index plunged 3.6% and tech stocks entered correction territory, highlighting investor focus on external foundry demand amid sector-wide profit-taking and supply chain concerns.
11 June 2026
····
Intel Stock’s Google-Fueled Rally Just Hit a Wall as AI Chip Bets Face a Reality Check

Intel Stock’s Google-Fueled Rally Just Hit a Wall as AI Chip Bets Face a Reality Check

Intel shares plunged 4.6% to $105.25 after Monday’s Google-fueled rally, as investors took profits and chip stocks broadly sold off; the drop highlights that Intel’s valuation now hinges on its ability to secure major foundry customers like Google, but the reported order remains unverified and sector-wide momentum is fading.
9 June 2026
····
Wall Street’s Chip Rebound Lifts Nasdaq — Inflation Test Comes Next

Wall Street’s Chip Rebound Lifts Nasdaq — Inflation Test Comes Next

Intel soared 8.5% to lead a 4.6% surge in chip stocks after reports Alphabet tapped it to make 3 million in-house chips and Nvidia was evaluating its technology, powering a 1.43% Nasdaq jump as investors returned to AI trades ahead of Wednesday’s key inflation data; Citigroup raised its S&P 500 target to 8,100, but Goldman Sachs warned the Fed may keep rates unchanged through 2026.
8 June 2026
·······
Intel’s AI Stock Run Stalls; Monday Premarket Move Fails to Settle It

Intel’s AI Stock Run Stalls; Monday Premarket Move Fails to Settle It

Intel shares rose 1.6% to $100.74 in pre-market trading Monday, partly rebounding from Friday’s 7.9% drop that followed a strong U.S. jobs report and a tech selloff; investors now face a key test as Intel’s AI partnerships with Foxconn and others lack visible orders or financial details, while options pricing signals potential for another 9% stock move this week amid inflation data and shifting rate expectations.
8 June 2026
Intel shares hit as AI chip slump wipes out $1.3 trillion

Intel shares hit as AI chip slump wipes out $1.3 trillion

Intel plunged 11.4% to $99.17 on heavy volume as the PHLX Semiconductor Index suffered its worst drop since March 2020, wiping out $1.3 trillion in U.S. chipmaker market value, overshadowing Intel’s new AI partnership with Foxconn amid sector-wide selling triggered by Broadcom’s guidance and renewed Fed rate hike fears.
6 June 2026
1 2 3 … 34

Stock Market Today

  • Valero Energy Stock Surges 96% in One Year: Is It Still Undervalued?
    June 12, 2026, 3:01 PM EDT. Valero Energy (NYSE: VLO) has surged 96.4% over the past year, driven by strong performance in the integrated refining sector and positive fuel demand trends. Despite a recent 1.3% dip, shares remain up 54.6% year-to-date. A Discounted Cash Flow (DCF) analysis estimates Valero's intrinsic value at $407.58 per share, significantly above its current price of around $255.60, suggesting a 37.3% undervaluation. The DCF model projects stable free cash flows in the mid-to-high single-digit billions through 2030. Valero scores 3 out of 6 on Simply Wall St's valuation scale, reflecting mixed indicators. Investors weigh the stock's strong rally against potential risks and valuation metrics as they consider opportunities in energy equities.

Latest articles

FreeCast Rallies on DIRECTV Deal, But Risks Remain for CAST

FreeCast Rallies on DIRECTV Deal, But Risks Remain for CAST

12 June 2026
FreeCast (NASDAQ: CAST) soared 147% to $1.59 on nearly 148 million shares after expanding its DIRECTV partnership to residential and Platform-as-a-Service channels, but the surge came amid extreme volatility, ongoing heavy losses, just $119,302 in cash, and a going-concern warning, with no new financial terms or subscriber targets disclosed.
Cuprina jumps after Nasdaq compliance update, but risks remain

Cuprina jumps after Nasdaq compliance update, but risks remain

12 June 2026
CUPR soared 74% to $4.20 after Cuprina said Nasdaq confirmed it had regained compliance with minimum bid price rules, removing immediate delisting risk following a 1-for-8 share consolidation; Friday’s rally reflects relief over trading continuity, but with 2025 revenue at just US$38,789 and net loss at US$3.63 million, investors now await proof of commercial traction in chronic wound care markets.
Go toTop